227 related articles for article (PubMed ID: 8430120)
41. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
Barrett AC; Miller JR; Dohrmann JM; Caine SB
Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
[TBL] [Abstract][Full Text] [Related]
42. The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists.
McCreary AC; Handley SL
Eur J Pharmacol; 1999 Mar; 369(1):1-9. PubMed ID: 10204674
[TBL] [Abstract][Full Text] [Related]
43. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
Jackson DM; Ross SB; Larsson LG
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
[TBL] [Abstract][Full Text] [Related]
44. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
45. Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet.
Baker RW; Osman J; Bodnar RJ
Pharmacol Biochem Behav; 2001; 69(1-2):201-8. PubMed ID: 11420087
[TBL] [Abstract][Full Text] [Related]
46. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
[TBL] [Abstract][Full Text] [Related]
47. Intact discrimination reversal learning but slowed responding to reward-predictive cues after dopamine D1 and D2 receptor blockade in the nucleus accumbens of rats.
Calaminus C; Hauber W
Psychopharmacology (Berl); 2007 Apr; 191(3):551-66. PubMed ID: 17021925
[TBL] [Abstract][Full Text] [Related]
48. Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists.
Fowler SC; Liou JR
Psychopharmacology (Berl); 1994 Jun; 115(1-2):24-30. PubMed ID: 7862901
[TBL] [Abstract][Full Text] [Related]
49. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists.
Ralph RJ; Paulus MP; Fumagalli F; Caron MG; Geyer MA
J Neurosci; 2001 Jan; 21(1):305-13. PubMed ID: 11150348
[TBL] [Abstract][Full Text] [Related]
50. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
Smith JK; Neill JC; Costall B
Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
[TBL] [Abstract][Full Text] [Related]
51. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
52. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.
Shi WX; Pun CL; Zhang XX; Jones MD; Bunney BS
J Neurosci; 2000 May; 20(9):3504-11. PubMed ID: 10777813
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions.
Wan RQ; Corbett R
Neuropsychopharmacology; 1997 Apr; 16(4):259-68. PubMed ID: 9094143
[TBL] [Abstract][Full Text] [Related]
54. Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control.
Pattij T; Janssen MC; Vanderschuren LJ; Schoffelmeer AN; van Gaalen MM
Psychopharmacology (Berl); 2007 Apr; 191(3):587-98. PubMed ID: 16972104
[TBL] [Abstract][Full Text] [Related]
55. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
56. Opposing roles of D1 and D2 receptors in appetitive conditioning.
Eyny YS; Horvitz JC
J Neurosci; 2003 Mar; 23(5):1584-7. PubMed ID: 12629161
[TBL] [Abstract][Full Text] [Related]
57. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors.
Lo PS; Wu CY; Sue HZ; Chen HH
Toxicology; 2009 Nov; 265(1-2):34-40. PubMed ID: 19765629
[TBL] [Abstract][Full Text] [Related]
58. Effects of dopamine receptor antagonism and amphetamine-induced psychomotor sensitization on sign- and goal-tracking after extended training.
Khoo SY; Uhrig A; Samaha AN; Chaudhri N
Behav Brain Res; 2021 Jun; 407():113238. PubMed ID: 33744334
[TBL] [Abstract][Full Text] [Related]
59. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
Parashos SA; Marin C; Chase TN
Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
[TBL] [Abstract][Full Text] [Related]
60. Development of conditioned place preference induced by intra-accumbens infusion of amphetamine is attenuated by co-infusion of dopamine D1 and D2 receptor antagonists.
Liao RM
Pharmacol Biochem Behav; 2008 May; 89(3):367-73. PubMed ID: 18275994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
